$AVAH
Aveanna Healthcare Holdings, Inc.

2023 Q1 Form 10-K Financial Statement

#000095017023008309 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $443.0M $1.679B
YoY Change 7.72% 12.27%
Cost Of Revenue $308.4M $1.136B
YoY Change 13.59% 9.19%
Gross Profit $134.6M $542.4M
YoY Change -3.69% 19.34%
Gross Profit Margin 30.38% 32.31%
Selling, General & Admin $89.54M $297.4M
YoY Change 17.25% 23.42%
% of Gross Profit 66.53% 54.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.917M $15.30M
YoY Change -4.43% 17.69%
% of Gross Profit 3.65% 2.82%
Operating Expenses $89.54M $297.4M
YoY Change 17.25% 23.42%
Operating Profit $4.787M -$36.11M
YoY Change -73.91% 935.59%
Interest Expense $28.46M $68.93M
YoY Change 135.11% -16.93%
% of Operating Profit 594.57%
Other Income/Expense, Net $45.14M $4.914M
YoY Change -8933.66% -85.74%
Pretax Income $21.63M -$113.6M
YoY Change 2084.75% 119.54%
Income Tax -$2.700M $3.468M
% Of Pretax Income -12.48%
Net Earnings $24.30M -$117.0M
YoY Change 1062.58% 105.16%
Net Earnings / Revenue 5.48% -6.97%
Basic Earnings Per Share $0.13 -$0.69
Diluted Earnings Per Share $0.13 -$686.0K
COMMON SHARES
Basic Shares Outstanding 185.9M 186.1M 170.6K
Diluted Shares Outstanding 186.2M 170.6K

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.68M $30.49M
YoY Change -47.68% -77.79%
Cash & Equivalents $63.68M $30.49M
Short-Term Investments
Other Short-Term Assets $9.764M $23.44M
YoY Change -8.68% 4.62%
Inventory
Prepaid Expenses $12.60M
Receivables $219.2M $225.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $312.1M $279.2M
YoY Change -8.94% -18.02%
LONG-TERM ASSETS
Property, Plant & Equipment $24.92M $83.37M
YoY Change -21.14% 5.66%
Goodwill $1.368B
YoY Change -3.61%
Intangibles $97.78M
YoY Change 25.98%
Long-Term Investments
YoY Change
Other Assets $92.50M $7.829M
YoY Change 933.93% -26.14%
Total Long-Term Assets $1.661B $2.055B
YoY Change 3.0% 36.7%
TOTAL ASSETS
Total Short-Term Assets $312.1M $279.2M
Total Long-Term Assets $1.661B $2.055B
Total Assets $1.973B $2.334B
YoY Change 0.91% 26.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.96M $52.62M
YoY Change 4.43% -7.19%
Accrued Expenses $62.49M $71.77M
YoY Change -9.66% 0.94%
Deferred Revenue $1.300M
YoY Change
Short-Term Debt $0.00 $7.451M
YoY Change -100.0% 156.93%
Long-Term Debt Due $9.200M $129.2M
YoY Change 6.98% 1130.48%
Total Short-Term Liabilities $351.7M $344.8M
YoY Change 60.17% 32.42%
LONG-TERM LIABILITIES
Long-Term Debt $1.283B $1.227B
YoY Change 54.59% 5.34%
Other Long-Term Liabilities $616.0K $121.3M
YoY Change -97.42% -2.16%
Total Long-Term Liabilities $1.283B $1.349B
YoY Change 50.34% 4.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $351.7M $344.8M
Total Long-Term Liabilities $1.283B $1.349B
Total Liabilities $1.743B $1.696B
YoY Change 45.38% 7.59%
SHAREHOLDERS EQUITY
Retained Earnings -$998.9M
YoY Change 122.74%
Common Stock $1.227B
YoY Change 1.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $227.9M $638.0M
YoY Change
Total Liabilities & Shareholders Equity $1.973B $2.334B
YoY Change 0.91% 26.59%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $24.30M -$117.0M
YoY Change 1062.58% 105.16%
Depreciation, Depletion And Amortization $4.917M $15.30M
YoY Change -4.43% 17.69%
Cash From Operating Activities $21.19M -$11.35M
YoY Change -40.82% -109.73%
INVESTING ACTIVITIES
Capital Expenditures -$2.815M $15.95M
YoY Change -33.42% 4.68%
Acquisitions $666.9M
YoY Change 274.03%
Other Investing Activities -$821.0K -$665.9M
YoY Change 17.79% 273.46%
Cash From Investing Activities -$3.636M -$681.8M
YoY Change -26.17% 252.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $477.7M
YoY Change 855.38%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.66M 586.3M
YoY Change -282.28% 177.95%
NET CHANGE
Cash From Operating Activities 21.19M -11.35M
Cash From Investing Activities -3.636M -681.8M
Cash From Financing Activities 28.66M 586.3M
Net Change In Cash 46.22M -106.9M
YoY Change 204.89% -179.73%
FREE CASH FLOW
Cash From Operating Activities $21.19M -$11.35M
Capital Expenditures -$2.815M $15.95M
Free Cash Flow $24.01M -$27.30M
YoY Change -40.04% -126.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 avah Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001832332
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q4 avah Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40362
CY2022 dei Entity Registrant Name
EntityRegistrantName
Aveanna Healthcare Holdings Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4717209
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
400 Interstate North Parkway SE
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2022 dei City Area Code
CityAreaCode
770
CY2022 dei Local Phone Number
LocalPhoneNumber
441-1580
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7829000
CY2022 dei Trading Symbol
TradingSymbol
AVAH
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
104300000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
185859165
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19217000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30490000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
221237000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
218917000
CY2022Q4 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
4395000
CY2022Q1 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
6373000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15089000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14233000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9813000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
9202000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
269751000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
279215000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22752000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31374000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54601000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51992000
CY2022Q4 us-gaap Goodwill
Goodwill
1159688000
CY2022Q1 us-gaap Goodwill
Goodwill
1835580000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95863000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102851000
CY2022Q4 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
22865000
CY2022Q1 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
25530000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86240000
CY2022Q4 us-gaap Assets
Assets
1711760000
CY2022Q1 us-gaap Assets
Assets
2334371000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188859165
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
44624000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
52624000
CY2022Q4 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
43836000
CY2022Q1 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
54565000
CY2022Q4 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
4395000
CY2022Q1 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
6373000
CY2022Q4 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
27531000
CY2022Q1 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
13466000
CY2022Q4 avah Securitization Obligations
SecuritizationObligations
140000000
CY2022Q1 avah Securitization Obligations
SecuritizationObligations
120000000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
9200000
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
8600000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13070000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13534000
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
25523000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43841000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
50146000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
326497000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
344831000
CY2022Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1281082000
CY2022Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1226517000
CY2022Q4 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
22865000
CY2022Q1 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
25530000
CY2022Q4 avah Long Term Insurance Reserves
LongTermInsuranceReserves
35470000
CY2022Q1 avah Long Term Insurance Reserves
LongTermInsuranceReserves
35122000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45818000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44682000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3844000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3046000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
359000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16692000
CY2022Q4 us-gaap Liabilities
Liabilities
1715935000
CY2022Q1 us-gaap Liabilities
Liabilities
1696420000
CY2022Q4 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2022Q1 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188859165
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
184732268
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
184732268
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1888000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1847000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1228512000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1208645000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1236710000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-574676000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6310000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
635816000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1711760000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2334371000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1787645000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1678618000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1234418000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1136214000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
357230000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
297381000
CY2022 avah Corporate Expenses
CorporateExpenses
137864000
CY2022 avah Corporate Expenses
CorporateExpenses
130387000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
675346000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
117702000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21313000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20550000
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
99000
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12832000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3651000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
337000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-642276000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-36111000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
679000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
253000
CY2022 us-gaap Interest Expense
InterestExpense
107720000
CY2022 us-gaap Interest Expense
InterestExpense
68930000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13702000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85503000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4914000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-663814000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-113576000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1780000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3468000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-662034000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-117044000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.57
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.57
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185553
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185553
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170625
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170625
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
265034000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
470108000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3189000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
970000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13559000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-117044000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
635816000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4015000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15893000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-662034000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6310000
CY2022 us-gaap Profit Loss
ProfitLoss
-662034000
CY2022 us-gaap Profit Loss
ProfitLoss
-117044000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21313000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20550000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7780000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8698000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17503000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14839000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
15893000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
14425000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
675346000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
117702000
CY2022 avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-3502000
CY2022 avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-110000
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
85367000
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
14317000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13702000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-115000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1313000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3227000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8808000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-9365000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6829000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1708000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4475000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3925000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11698000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-10729000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-14026000
CY2022 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
18154000
CY2022 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
2112000
CY2022 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-19621000
CY2022 avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-15687000
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
25523000
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
25876000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
5009000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8649000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48402000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
58959000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11350000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2013000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
666915000
CY2022 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
460000
CY2022 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
11725000
CY2022 us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
853000
CY2022 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
1887000
CY2022 avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
12013000
CY2022 avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
15950000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25291000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-681831000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
477688000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
970000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4015000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2323000
CY2022 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
40000000
CY2022 us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
150000000
CY2022 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
20000000
CY2022 us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
30000000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
15000000
CY2022 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
59700000
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1324531000
CY2022 avah Repayment Of Term Loans
RepaymentOfTermLoans
8900000
CY2022 avah Repayment Of Term Loans
RepaymentOfTermLoans
1273883000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9852000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
8262000
CY2022 avah Proceeds From Government Stimulus Funds
ProceedsFromGovernmentStimulusFunds
2455000
CY2022 avah Repayment Of Government Stimulus Funds
RepaymentOfGovernmentStimulusFunds
31899000
CY2022 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
799000
CY2022 avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
795000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5473000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
218000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
15231000
CY2022 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
1526000
CY2022 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
4192000
CY2022 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1906000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62420000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
586326000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11273000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-106855000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30490000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
137345000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19217000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30490000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
102532000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1586000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5279000
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p id="footnotes_to_financial_statements" style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. DESCRI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PTION OF BUSINESS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> states </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with concentrations in Texas, Pennsylvania, and California, providing a broad range of pediatric and adult healthcare services, including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Initial Public Offering</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 3, 2021, the Company completed the initial public offering (“IPO”) of its common stock pursuant to a Registration Statement on Form S-1 (File No. 333-254981), which was declared effective by the SEC on April 28, 2021. The Company issued and sold an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,236,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, including </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock purchased by the underwriters on May 25, 2021 pursuant to the underwriters’ option to purchase additional shares at the initial public offering price, less underwriting discounts and commissions. The Company received net proceeds from the IPO of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. On May 3, 2021, the Company used </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">307.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of proceeds to repay in full all outstanding obligations under the second lien credit agreement dated as of March 16, 2017 (as amended, the “Prior Second Lien Credit Agreement”), thereby terminating the Prior Second Lien Credit Agreement. In addition, on May 4, 2021, the Company used </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of proceeds to repay an equal amount of principal outstanding under its First Lien Credit Agreement (as defined in Note 6 – </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Long-term Obligations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). The remaining proceeds were used for offering costs and general corporate purposes, including acquisitions.</span></p>
CY2022Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
CY2021Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
477700000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
0
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83461000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
78353000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60709000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
46979000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22752000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31374000
CY2022 us-gaap Depreciation
Depreciation
15200000
CY2022 us-gaap Depreciation
Depreciation
15300000
CY2022 avah Current Leases Expiration Year
CurrentLeasesExpirationYear
2030
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
470200000
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
205100000
CY2022 avah Number Of Reporting Units Require Goodwill Impairment Testing
NumberOfReportingUnitsRequireGoodwillImpairmentTesting
6
CY2022 avah Number Of Reporting Units Require Goodwill Impairment Testing
NumberOfReportingUnitsRequireGoodwillImpairmentTesting
8
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1700000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
7400000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
8700000
CY2022 us-gaap Marketing Expense
MarketingExpense
6000000.0
CY2022 us-gaap Marketing Expense
MarketingExpense
2900000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of patient accounts receivable. Should government agencies suspend or significantly reduce contributions to government insurance programs, the Company’s ability to collect its receivables would be adversely affected. The Company’s exposure to credit risk with respect to its remaining receivables is limited due to the large number of state Medicaid, Medicaid Managed Care Organization payers, and Medicare Advantage payers.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is also subject to credit risk due to the variable interest rates on its term loan obligations. As a result, the Company has entered into interest caps and interest rate swap agreements to limit its exposure to risk on its variable rate debt. See Note 9 – </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Derivative Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for further details on the interest rate derivative instruments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company maintains its cash in bank deposit accounts with major financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to significant credit risk on cash and cash equivalents.</span></p>
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
88076000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
133204000
CY2021Q2 avah Reclassification Of Deferred Offering Cost Into Equity
ReclassificationOfDeferredOfferingCostIntoEquity
7600000
CY2022Q4 avah Estimated Price Concession
EstimatedPriceConcession
52600000
CY2022Q1 avah Estimated Price Concession
EstimatedPriceConcession
55800000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2021Q1 us-gaap Goodwill
Goodwill
1316385000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
635230000
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
1667000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
117702000
CY2022Q1 us-gaap Goodwill
Goodwill
1835580000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
920000
CY2022 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-1466000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
675346000
CY2022Q4 us-gaap Goodwill
Goodwill
1159688000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39337000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31550000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7787000
CY2022Q4 avah Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
93867000
CY2022Q4 avah Indefinite Lived Intangible Assets Accumulated Impairment
IndefiniteLivedIntangibleAssetsAccumulatedImpairment
5791000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31550000
CY2022Q4 avah Intangible Assets Accumulated Impairment
IntangibleAssetsAccumulatedImpairment
5791000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95863000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38803000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25555000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13248000
CY2022Q1 avah Indefinite Lived Intangible Assets Gross Excluding Goodwill
IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
93696000
CY2022Q1 avah Indefinite Lived Intangible Assets Accumulated Impairment
IndefiniteLivedIntangibleAssetsAccumulatedImpairment
4093000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
89603000
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
132499000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25555000
CY2022Q1 avah Intangible Assets Accumulated Impairment
IntangibleAssetsAccumulatedImpairment
4093000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102851000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6000000.0
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4600000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2270000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1218000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
713000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
713000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
713000
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2160000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7787000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
9200000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1277950000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1323950000
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
20490000
CY2022Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
24909000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1056000
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3671000
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
6175000
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
5111000
CY2022Q4 avah Tax Refund Due To Seller Current
TaxRefundDueToSellerCurrent
6783000
CY2022Q1 avah Tax Refund Due To Seller Current
TaxRefundDueToSellerCurrent
7451000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
9337000
CY2022Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
9004000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43841000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
50146000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1323950000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1272850000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
33668000
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
37733000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1290282000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1235117000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8600000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1281082000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226517000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
9200000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9200000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
9200000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9200000
CY2021Q2 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
8900000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-400000
CY2021Q3 avah Corporate Expenses
CorporateExpenses
7000000.0
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
7400000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
8700000
CY2022Q4 avah Swingline Loan
SwinglineLoan
0
CY2022Q1 avah Swingline Loan
SwinglineLoan
0
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
954900000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
81750000
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
15342000
CY2022Q4 avah Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2022Q1 avah Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2022Q4 avah Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2022Q1 avah Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q1 avah Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2022Q1 avah Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q4 avah Tax Cuts And Jobs Act Transition Tax For Research And Development Expenses
TaxCutsAndJobsActTransitionTaxForResearchAndDevelopmentExpenses
4500000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-2323000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
581000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
658000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1574000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1665000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2155000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1561000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1231000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1446000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2544000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-115000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1313000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1780000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3468000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.034
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.094
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.170
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.016
CY2022 avah Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
-0.004
CY2022 avah Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
-0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.116
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.031
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.003
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.031
CY2022Q4 avah Deferred Tax Assets Contractual Adjustments And Discounts
DeferredTaxAssetsContractualAdjustmentsAndDiscounts
13589000
CY2022Q1 avah Deferred Tax Assets Contractual Adjustments And Discounts
DeferredTaxAssetsContractualAdjustmentsAndDiscounts
14519000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30175000
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19628000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2688000
CY2022Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2270000
CY2022Q4 avah Deferred Tax Assets Payroll Related Accruals
DeferredTaxAssetsPayrollRelatedAccruals
18742000
CY2022Q1 avah Deferred Tax Assets Payroll Related Accruals
DeferredTaxAssetsPayrollRelatedAccruals
23562000
CY2022Q4 avah Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
101483000
CY2022Q1 avah Deferred Tax Assets Intangible Assets
DeferredTaxAssetsIntangibleAssets
22270000
CY2022Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
59871000
CY2022Q1 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
34931000
CY2022Q4 avah Deferred Tax Assets Transaction Costs
DeferredTaxAssetsTransactionCosts
3608000
CY2022Q1 avah Deferred Tax Assets Transaction Costs
DeferredTaxAssetsTransactionCosts
4171000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3642000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
4494000
CY2022Q1 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
4073000
CY2022Q4 avah Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
15589000
CY2022Q1 avah Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
15740000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8481000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5119000
CY2022Q4 avah Deferred Tax Assets Section174 Costs
DeferredTaxAssetsSection174Costs
1079000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
310000
CY2022Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
254000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
259257000
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
151031000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
203370000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
105000000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
55887000
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46031000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1363000
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3281000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
20854000
CY2022Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
26621000
CY2022Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
18456000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
14254000
CY2022Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
13751000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
4804000
CY2022Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
5424000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
59731000
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
49077000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3844000
CY2022Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3046000
CY2022 avah Operating Loss Carryforwards Expiration Start Year
OperatingLossCarryforwardsExpirationStartYear
2021
CY2022 avah Operating Loss Carryforwards Expiration End Period
OperatingLossCarryforwardsExpirationEndPeriod
2038
CY2022 avah Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act
MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct
0.30
CY2021 avah Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act
MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct
0.50
CY2019 avah Maximum Percentage Of Taxpayers Adjusted Taxable Income Under Cares Act
MaximumPercentageOfTaxpayersAdjustedTaxableIncomeUnderCaresAct
0.50
CY2022Q4 avah Indefinite Lived Interest Expense Carryovers
IndefiniteLivedInterestExpenseCarryovers
252500000
CY2022Q4 avah Deferred Tax Asset Interest Carryforward Not Subject To Expiration
DeferredTaxAssetInterestCarryforwardNotSubjectToExpiration
59900000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
203400000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
98400000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
105000000.0
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
105000000
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
94041000
CY2022 avah Valuation Allowance Recorded Through Purchase Accounting
ValuationAllowanceRecordedThroughPurchaseAccounting
1156000
CY2022 avah Increase Decrease Deferred Tax Assets Valuation Allowances
IncreaseDecreaseDeferredTaxAssetsValuationAllowances
98370000
CY2022 avah Increase Decrease Deferred Tax Assets Valuation Allowances
IncreaseDecreaseDeferredTaxAssetsValuationAllowances
9803000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
203370000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
105000000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8100000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10200000
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1800000
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
2000000.0
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9900000
CY2022Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
1000000.0
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2100000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10240000
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6182000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
214000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
4846000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2105000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1002000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8135000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10240000
CY2021Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
477700000
CY2022 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
effected a one-to-20.5 forward stock split
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
20.5
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2100000
CY2022Q4 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2100000
CY2022 avah Current Leases Expiration Year
CurrentLeasesExpirationYear
2030
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54601000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51992000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13070000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13534000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45818000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
44682000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
58888000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
58216000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
21898000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
19326000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
21898000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
19326000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
3328000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
3206000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1640000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1919000
CY2022 us-gaap Lease Cost
LeaseCost
26866000
CY2022 us-gaap Lease Cost
LeaseCost
24451000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
22626000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
19697000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20273000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22927000
CY2022 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
799000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M7D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M14D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0748
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0829
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18541000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17212000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13705000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9763000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5632000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4827000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
69680000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10792000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
58888000
CY2022 us-gaap Lessee Finance Lease Description
LesseeFinanceLeaseDescription
Financing leases include provisions to purchase the asset at the conclusion of the lease. There were no financing assets as of December 31, 2022 and $0.9 million of financing assets as of January 1, 2022 in property and equipment, net on the consolidated balance sheets. Financing liabilities of $0.7 million are included in other current liabilities on the consolidated balance sheets as of December 31, 2022. Financing liabilities of $0.6 million and $0.7 million are included in other current liabilities and other long-term liabilities, respectively, on the consolidated balance sheets as of January 1, 2022.
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2022Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
900000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
700000
CY2022Q1 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding
0
CY2022Q4 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services Outstanding
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServicesOutstanding
0
CY2022Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
600000
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
700000
CY2022Q4 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
1500000
CY2022Q4 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
5000000.0
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
90300000
CY2022Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
80500000
CY2018Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
75000000.0
CY2019Q4 avah Break Up Fee Payable
BreakUpFeePayable
0
CY2022 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Epic/Freedom, LLC (“Seller”), Webster Capital Corporation, and Webster Equity Partners (collectively, the “Defendants”)
CY2020Q3 us-gaap Escrow Deposit
EscrowDeposit
7100000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6400000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
4800000
CY2022 avah Provider Relief Fund Payments Received Cares Act
ProviderReliefFundPaymentsReceivedCARESAct
25100000
CY2021Q4 avah Provider Relief Fund Payments Received Cares Act
ProviderReliefFundPaymentsReceivedCARESAct
2500000
CY2021 avah Incremental Percentage Of Deferred Payment Of Employer Portion Of Social Security Taxes
IncrementalPercentageOfDeferredPaymentOfEmployerPortionOfSocialSecurityTaxes
0.50
CY2021Q4 avah Percentage Of Social Security Tax Due Cares Act
PercentageOfSocialSecurityTaxDueCARESAct
0.50
CY2022Q4 avah Percentage Of Social Security Tax Due Cares Act
PercentageOfSocialSecurityTaxDueCARESAct
0.50
CY2021Q4 avah Deferred Payroll Taxes Cares Act Paid
DeferredPayrollTaxesCaresActPaid
25900000
CY2022Q1 avah Deferred Payroll Taxes Current Cares Act
DeferredPayrollTaxesCurrentCaresAct
25500000
CY2022Q4 avah Deferred Social Security Tax Cares Act
DeferredSocialSecurityTaxCARESAct
25500000
CY2021Q1 avah Arpa Recovery Funds
ArpaRecoveryFunds
350000000000
CY2022 avah Arpa Recovery Funds
ArpaRecoveryFunds
6300000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000000.0
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1300000
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
800000
CY2022Q4 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
0
CY2022Q1 avah Advisory Services Expense Outstanding
AdvisoryServicesExpenseOutstanding
0
CY2022 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices
400000
CY2022 avah Ownership Interest In Revenue Cycle Vendor Eligibility And Clearing House Billing Services
OwnershipInterestInRevenueCycleVendorEligibilityAndClearingHouseBillingServices
400000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1787645000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1234418000
CY2022 us-gaap Gross Profit
GrossProfit
553227000
CY2022 avah Gross Margin Percentage
GrossMarginPercentage
0.309
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1678618000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1136214000
CY2022 us-gaap Gross Profit
GrossProfit
542404000
CY2022 avah Gross Margin Percentage
GrossMarginPercentage
0.323
CY2022 us-gaap Gross Profit
GrossProfit
553227000
CY2022 us-gaap Gross Profit
GrossProfit
542404000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
357230000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
297381000
CY2022 avah Corporate Expenses
CorporateExpenses
137864000
CY2022 avah Corporate Expenses
CorporateExpenses
130387000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
675346000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
117702000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21313000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20550000
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
99000
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12832000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3651000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
337000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-642276000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-36111000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
679000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
253000
CY2022 us-gaap Interest Expense
InterestExpense
107720000
CY2022 us-gaap Interest Expense
InterestExpense
68930000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13702000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
85503000
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4914000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-663814000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-113576000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-662034000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-117044000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185553
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185553
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170625
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170625
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.57
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.57
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69

Files In Submission

Name View Source Status
0000950170-23-008309-index-headers.html Edgar Link pending
0000950170-23-008309-index.html Edgar Link pending
0000950170-23-008309.txt Edgar Link pending
0000950170-23-008309-xbrl.zip Edgar Link pending
avah-20221231.htm Edgar Link pending
avah-20221231.xsd Edgar Link pending
avah-ex10_26.htm Edgar Link pending
avah-ex10_27.htm Edgar Link pending
avah-ex21_1.htm Edgar Link pending
avah-ex23_1.htm Edgar Link pending
avah-ex31_1.htm Edgar Link pending
avah-ex31_2.htm Edgar Link pending
avah-ex32_1.htm Edgar Link pending
avah-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img22852046_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
avah-20221231_cal.xml Edgar Link unprocessable
avah-20221231_def.xml Edgar Link unprocessable
avah-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avah-20221231_lab.xml Edgar Link unprocessable
avah-20221231_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending